Characteristics and impact of drug detailing for gabapentin (Q28469192)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Characteristics and impact of drug detailing for gabapentin	scientific article

Statements

scholarly article

0 references

Characteristics and impact of drug detailing for gabapentin (English)

0 references

0 references

5

object named as

Lisa A Bero

0 references

C Seth Landefeld

4

object named as

C Seth Landefeld

0 references

author name string

Michael A Steinman

1

0 references

G Michael Harper

2

0 references

Mary-Margaret Chren

3

0 references

language of work or name

0 references

publication date

April 2007

0 references

0 references

4

0 references

4

0 references

e134

0 references

copyright license

Creative Commons CC0 License

24 April 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

For sale: physicians' prescribing data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

19 March 2017

Interactions between pharmaceutical representatives and doctors in training. A thematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

19 March 2017

Gabapentin for acute and chronic pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

19 March 2017

Anticonvulsant drugs for migraine prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

19 March 2017

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

19 March 2017

Narrative review: the promotion of gabapentin: an analysis of internal industry documents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Doctors and drug companies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

A social science perspective on gifts to physicians from industry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Physicians and the pharmaceutical industry: is a gift ever just a gift?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

What information do physicians receive from pharmaceutical representatives?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Characteristics of materials distributed by drug companies. An evaluation of appropriateness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Interactions between physicians and the pharmaceutical industry: what does the literature say?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Attitudes of general practitioners in New Zealand to pharmaceutical representatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Continuing education for general practice and the role of the pharmaceutical industry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Patterns of preference for information sources in the adoption of new drugs by specialists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

29 September 2017

Promotion of prescription drugs to consumers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

2 June 2018

Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

2 June 2018

Reasons for not seeing drug representatives. They should be seen because they are a good resource

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

2 June 2018

Principles of educational outreach ('academic detailing') to improve clinical decision making

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

2 June 2018

Content analysis of drug-detailing by pharmaceutical representatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

2 June 2018

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

20 June 2018

Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Student understanding of the relationship between the health professions and the pharmaceutical industry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Assessing the quality of drug detailing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Teaching information mastery: evaluating information provided by pharmaceutical representatives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Physicians, pharmaceutical sales representatives, and the cost of prescribing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

The accuracy of drug information from pharmaceutical sales representatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

27 November 2018

Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reasons for not seeing drug representatives. Drug representatives have much to offer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention to 'details': etiquette and the pharmaceutical salesman in postwar American

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of commercial sources in the adoption of a new drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doctors, drug companies, and gifts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff

1 reference

https://pubmed.ncbi.nlm.nih.gov/17455990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PMED.0040134

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28469192&oldid=2114079962"